Back
Full-text
Journal article

Costs and Cost-Effectiveness of Plasmodium vivax Control.

  • White MT MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
  • Yeung S Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Patouillard E Universität Basel, Basel, Switzerland.
  • Cibulskis R Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Show more…
  • 2016-12-28
Published in:
  • The American journal of tropical medicine and hygiene. - 2016
Animals
Antimalarials
Cost-Benefit Analysis
Culicidae
Humans
Malaria, Vivax
Mosquito Control
Plasmodium vivax
English The continued success of efforts to reduce the global malaria burden will require sustained funding for interventions specifically targeting Plasmodium vivax The optimal use of limited financial resources necessitates cost and cost-effectiveness analyses of strategies for diagnosing and treating P. vivax and vector control tools. Herein, we review the existing published evidence on the costs and cost-effectiveness of interventions for controlling P. vivax, identifying nine studies focused on diagnosis and treatment and seven studies focused on vector control. Although many of the results from the much more extensive P. falciparum literature can be applied to P. vivax, it is not always possible to extrapolate results from P. falciparum-specific cost-effectiveness analyses. Notably, there is a need for additional studies to evaluate the potential cost-effectiveness of radical cure with primaquine for the prevention of P. vivax relapses with glucose-6-phosphate dehydrogenase testing.
Language
  • English
Open access status
hybrid
Identifiers
Persistent URL
https://sonar.ch/global/documents/232329
Statistics
Document views: 14 File downloads:
  • fulltext.pdf: 0